GSK announces $350M cancer deal

4:05 AM ET Mon, 2 June 2014

GlaxoSmithKline has announced a $350 million deal with U.K. biotech company Adaptimmune which could be a "real shift" in the way cancer is treated, CNBC's Catherine Boyle reports.